Outcome and biomarker analysis from a multi-centre phase 2 study of ipilimumab in combination with carboplatin and etoposide (ICE) as first line therapy for extensive stage small cell lung cancer.

Arriola, E., Wheater, M., Galea, I. et al. (13 more authors) (2016) Outcome and biomarker analysis from a multi-centre phase 2 study of ipilimumab in combination with carboplatin and etoposide (ICE) as first line therapy for extensive stage small cell lung cancer. Journal of Thoracic Oncology, 11 (9). pp. 1511-1521. ISSN 1556-0864

Abstract

Metadata

Authors/Creators:
  • Arriola, E.
  • Wheater, M.
  • Galea, I.
  • Cross, N.
  • Maishman, T.
  • Hamid, D.
  • Stanton, L.
  • Cave, J.
  • Geldart, T.
  • Mulatero, C.
  • Potter, V.
  • Danson, S.
  • Woll, P.J.
  • Griffiths, R.
  • Nolan, L.
  • Ottensmeier, C.
Copyright, Publisher and Additional Information: © 2016 Elsevier Ltd. This is an author produced version of a paper subsequently published in Journal of Thoracic Oncology. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Dates:
  • Accepted: 23 May 2016
  • Published (online): 11 June 2016
  • Published: September 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 13 Jul 2016 14:08
Last Modified: 05 Aug 2017 07:49
Published Version: https://dx.doi.org/10.1016/j.jtho.2016.05.028
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jtho.2016.05.028
Related URLs:

Share / Export

Statistics